Atlas Trials

LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial

Clinical trial NCT07645300 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07645300
Sponsor
VA Office of Research and Development
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hypertension Treated With Antihypertensive DrugsChronic Kidney Disease, 3B and 4
Start date
2026-10-01
Primary completion
2032-03-31
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.